James Price, DO
Pain Medicine · Palmer, AKNPI 1306898705
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (34.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Nevro Corp. at 48.6% of the total. Reporting peaked in 2023 at $3,546 and has fallen 89.7% since, to $365 in 2025.
Across 82 payments — averaging $85.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$3K
- Medtronic$2K
- AbbVie$610
- Avanos Medical$163
- AstraZeneca$137
- Globus Medical$82
- plus $318 from 14 others
What the payments were for
- Travel & lodging$2,36634%
- Food & beverage$2,27232%
- Education$2,38834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 20 | $3,414 |
| Medtronic | 19 | $2,300 |
| AbbVie | 17 | $610 |
| Avanos Medical | 6 | $163 |
| AstraZeneca | 2 | $137 |
| Globus Medical | 1 | $82 |
| Merck | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Pfizer | 1 | $22 |
| Abbott | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Vertex | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Stryker | 1 | $15 |
| Eagle Pharmaceuticals, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$2,903
- INTELLIS ADAPTIVESTIM$1,054
- SYNCHROMEDII$776
- BREZTRI$125
- VRAYLAR$125
- UBRELVY$124
- PNB AND ACCESSORIES$117
How this compares
$7,025 in reported general payments places this provider in the 75th percentile of 20 pain medicine providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 14 | $11,073 |
| Buprenorphine | 15 | $6,336 |
| Celecoxib | 78 | $5,171 |
| Fentanyl | 55 | $4,968 |
| Gabapentin | 177 | $3,387 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $3,213 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 94 | $3,137 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 121 | $3,089 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $2,114 |
| Buprenorphine Hcl | 55 | $1,780 |
| Oxycodone Hcl | 68 | $1,418 |
| Methadone Hcl | 39 | $962 |
| Pregabalin | 42 | $830 |
| Lidocaine | 12 | $802 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 25 | $738 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Palmer
- Stephen MarkewichWasilla$57K
- Renee MarchegianiWasilla$10K
- Derek BradleyJber$9K
- Kimpreet KaurElmendorf Afb$7K
- Nichelle RenkAnchorage$5K
- Jon HinmanWasilla$2K
- Benjamin EkstromAnchorage$910
- Leon ChandlerAnchorage$836
- Nancy CrossFairbanks$707
- Shawn JohnstonAnchorage$663
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.